Acquired

Comprehend Systems Stock
Comprehend is a technology company with a new class of cloud software to help ClinOps teams continuously improve speed and quality.
Sign up today and learn more about Comprehend Systems Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Comprehend Systems Stock
Comprehend is a technology company with a new class of cloud software to help Clinical Operations continuously improve the speed, efficiency and quality of clinical trials across its portfolio of studies. For the first time, teams are given a single system with powerful data aggregation, monitoring, collaboration and analytic capabilities to actively manage enrollment funnels, patient compliance, data quality and site productivity across systems, studies and sites. The Continuous Quality Solution (CQS) goes beyond traditional site monitoring, giving ClinOps teams and executives portfolio monitoring on their key performance and risk indicators to significantly lower the cost, time and risk to deliver milestones on-time. The most demanding life sciences companies including Merck, AstraZeneca and Astellas, as well as ClinOps innovators such as bluebird bio and Jazz Pharmaceuticals, trust Comprehend CQS to provide the confidence necessary to deliver high-quality clinical trial submissions at a new speed. Comprehend: the speed to quality results. Visit Comprehend at www.comprehend.com.
Funding History
November 2011 | $1.2M |
---|---|
July 2013 | $8.5M |
August 2014 | $21.0M |
February 2017 | $15.0M |
Management
Chief Revenue Officer
Kevin Kennedy
CMO and Head of Product
Rani Hublou
Founder & CTO
Jud Gardner
Founder and President
Rick Morrison
Investor
Lyon Wong
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase